Payment overview · 2025
General Payments
$28.29
1 reported records · 1 companies
Healthcare provider profile · identity verified
David John Whitmore, DO
Allopathic & Osteopathic Physicians|General Practice · HUNTINGTON, WV · NPI 1275511404
Verified facts
What the public records show
CMS Open Payments records show David John Whitmore, DO received $28.29 in general payments during 2025 across 1 reported records.
Haemonetics Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Haemonetics Corporation | Unresolved — no canonical attribution shown | $28.29 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $28.29 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TEG6S HEMOSTASIS SYSTEM Normalized: teg6s hemostasis system |
Device | Haemonetics Corporation | $28.29 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 609 | 168 |
| Omeprazole | Omeprazole | 498 | 140 |
| Amlodipine Besylate | Amlodipine Besylate | 425 | 122 |
| Losartan Potassium | Losartan Potassium | 385 | 106 |
| Levothyroxine Sodium | Levothyroxine Sodium | 354 | 91 |
| Fluticasone Propionate | Fluticasone Propionate | 327 | 135 |
| Lisinopril | Lisinopril | 327 | 93 |
| Montelukast Sodium | Montelukast Sodium | 267 | 77 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 259 | 86 |
| Pantoprazole Sodium | Pantoprazole Sodium | 234 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 218 | 66 |
| Fenofibrate | Fenofibrate | 204 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 201 | 58 |
| Furosemide | Furosemide | 198 | 73 |
| Citalopram Hbr | Citalopram Hydrobromide | 195 | 58 |
| Trazodone Hcl | Trazodone Hcl | 192 | 58 |
| Potassium Chloride | Potassium Chloride | 189 | 66 |
| Famotidine | Famotidine | 180 | 66 |
| Tizanidine Hcl | Tizanidine Hcl | 179 | 57 |
| Gabapentin | Gabapentin | 165 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 163 | 53 |
| Metformin Hcl | Metformin Hcl | 147 | 49 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 146 | 46 |
| Simvastatin | Simvastatin | 140 | 42 |
| Prednisone | Prednisone | 137 | 93 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 132 | 36 |
| Alendronate Sodium | Alendronate Sodium | 125 | 37 |
| Alprazolam | Alprazolam | 119 | 17 |
| Tramadol Hcl | Tramadol Hcl | 119 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 108 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 104 | 34 |
| Doxycycline Hyclate | Doxycycline Hyclate | 104 | 80 |
| Ozempic | Semaglutide | 103 | 23 |
| Sertraline Hcl | Sertraline Hcl | 103 | 33 |
| Cefdinir | Cefdinir | 102 | 67 |
| Metformin Hcl Er | Metformin Hcl | 100 | 30 |
| Ondansetron Odt | Ondansetron | 98 | 53 |
| Fluconazole | Fluconazole | 94 | 52 |
| Januvia | Sitagliptin Phosphate | 94 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 94 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 90 | 29 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 89 | 35 |
| Diclofenac Sodium | Diclofenac Sodium | 86 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 86 | 29 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 85 | 85 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 85 | 23 |
| Allopurinol | Allopurinol | 83 | 22 |
| Amitriptyline Hcl | Amitriptyline Hcl | 80 | 21 |
| Bupropion Xl | Bupropion Hcl | 80 | 26 |
| Eliquis | Apixaban | 77 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 77 | 30 |
| Donepezil Hcl | Donepezil Hcl | 75 | 19 |
| Amoxicillin | Amoxicillin | 74 | 56 |
| Duloxetine Hcl | Duloxetine Hcl | 74 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 74 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 73 | 18 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 72 | 54 |
| Meloxicam | Meloxicam | 71 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 69 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 67 | 24 |
| Ventolin Hfa | Albuterol Sulfate | 67 | 25 |
| Cephalexin | Cephalexin | 66 | 51 |
| Atenolol | Atenolol | 63 | 18 |
| Symbicort | Budesonide/Formoterol Fumarate | 62 | 26 |
| Carvedilol | Carvedilol | 57 | 18 |
| Warfarin Sodium | Warfarin Sodium | 56 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 55 | suppressed |
| Lovastatin | Lovastatin | 54 | 13 |
| Clonazepam | Clonazepam | 53 | suppressed |
| Ezetimibe | Ezetimibe | 52 | 16 |
| Glipizide | Glipizide | 49 | 13 |
| Synthroid | Levothyroxine Sodium | 49 | 15 |
| Finasteride | Finasteride | 48 | 16 |
| Nystatin | Nystatin | 47 | 25 |
| Spironolactone | Spironolactone | 46 | 12 |
| Valacyclovir | Valacyclovir Hcl | 46 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 45 | 15 |
| Primidone | Primidone | 45 | 12 |
| Ibuprofen | Ibuprofen | 43 | 16 |
| Azithromycin | Azithromycin | 42 | 26 |
| Meclizine Hcl | Meclizine Hcl | 42 | 18 |
| Diazepam | Diazepam | 41 | 11 |
| Linzess | Linaclotide | 41 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | 11 |
| Nifedipine Er | Nifedipine | 39 | 11 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 38 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 36 | 20 |
| Pregabalin | Pregabalin | 36 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 35 | suppressed |
| Lorazepam | Lorazepam | 34 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 33 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 33 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 33 | suppressed |
| Klor-Con M20 | Potassium Chloride | 33 | 12 |
| Glimepiride | Glimepiride | 31 | suppressed |
| Nitroglycerin | Nitroglycerin | 31 | 13 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | 12 |
| Jardiance | Empagliflozin | 30 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 30 | 25 |
| Chlorthalidone | Chlorthalidone | 29 | suppressed |
| Glipizide Er | Glipizide | 28 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 28 | suppressed |
| Tradjenta | Linagliptin | 28 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 27 | suppressed |
| Sucralfate | Sucralfate | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | 18 |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 24 |
| Spiriva Handihaler | Tiotropium Bromide | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 23 | suppressed |
| Glyburide | Glyburide | 23 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 22 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | 12 |
| Metronidazole | Metronidazole | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 20 |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Mirtazapine | Mirtazapine | 19 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 18 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | suppressed |
| Temazepam | Temazepam | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Levetiracetam | Levetiracetam | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Cimetidine | Cimetidine | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 14 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 14 | suppressed |
| Baclofen | Baclofen | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Selenium Sulfide | Selenium Sulfide | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Dofetilide | Dofetilide | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 12 | 12 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Clotrimazole | Clotrimazole | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $28.29 · 1 records | Haemonetics Corporation | TEG6S HEMOSTASIS SYSTEM | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error